ORIGEM

Welcome to the Brand page for “ORIGEM”, which is offered here for Human pharmaceuticals for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, dermatologic disorders, metabolic diseases, anti-viral diseases, oncologic diseases, respiratory diseases, ophthalmic diseases, muscle dystonias, wrinkles and smooth muscle disorders, gastro-intestinal diseases, pain; human pharmaceuticals for use as hemostatic agents;the english translation of origem in the mark is origin.;.

Its status is currently believed to be active. Its class is unavailable. “ORIGEM” is believed to be currently owned by “JANSSEN SCIENCES IRELAND UC”.